SABER

El impresionante universo de los venenos, su variabilidad bioquímica, hemostática y tóxica en las serpientes (Serpentes: Viperidae) Porthidium y Bothrops | The impressive universe of the venoms, their biochemical, haemostatic and toxic variability in Porthidium and Bothrops (Serpentes: Viperidae) snakes

Resumen

AGUILAR I, GUERRERO B, SALAZAR AM, GIRÓN ME, PÉREZ JC, SÁNCHEZ EE, RODRÍGUEZ-ACOSTA A. 2007. Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis. Toxicon. 50(2):214-224.

ALAPÉ-GIRÓN A, SANZ L, ESCOLANO J, FLORES-DÍAZ M, MADRIGAL M, SASA M, CALVETE J. 2008. Snake venomics of the Lancehead Pitviper Bothrops asper: geographic, individual and ontogenic variations. J. Proteome Res. 7(8):3556-3571.

ANDREWS R, BERNDT M. 2000. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon. 38(6):775-791.

ANGULO Y, ESCOLANO J, LOMONTE B, GUTIERREZ JM, SANZ L, CALVETE J. 2008. Snake venomics of Central American Pittvipers: clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi. J. Proteom. Res. 7(2):708-719.

ARAKI S, MASUDA S, MAEDA H, YING MJ, HAYASHI H. 2002. Involvement of specific integrins in apoptosis induced by vascular apoptosis-inducing protein 1. Toxicon. 40(5):535-542.

ARRUDA M, FOX J, DE SOUZA M. 2015. Disintegrins from snake venoms and their applications in cancer research and therapy. Curr. Protein Pept. Sci. 16(6):532-548.

BALDO C, JAMORA C, YAMANOUYE N, ZORN N, MOURA-DA-SILVA A. 2010. Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Negl. Trop. Dis. 4(6):e727.

BJARNASON B, FOX JW. 1994. Hemorrhagic metalloproteinases from snake venoms. Pharmacol. Ther. 62(3):325-372.

BODE W, KRESS L, MEYER E, GOMIS-RÜTH F. 1994. The crystal structure of adamalysin II, a zinc-endopeptidase from the snake venom of the eastern diamondback rattlesnake Crotalus adamanteus. Braz. J. Med. Biol. Res. 27(8):2049-2068.

BRENES O, MUÑÓZ E, ROLDÁN-RODRÍGUEZ R, DÍAZ C. 2010. Cell death induced by Bothrops asper snake venom metalloproteinase on endothelial and other cell lines. Exp. Mol. Pathol. 88(3):424-432.

CALVETE J. 2009. Studies on the venom proteome of Bothrops asper: perspectives and applications. Toxicon. 54(7):938-948.

CALVETE J. 2013. The continuing saga of snake venom disintegrins. Toxicon. 62:40-49.

CALVETE JJ, BORGES A, SEGURA A, FLÓRES-DÍAZ M, ALAPÉ-GIRÓN A, GUTIÉRREZ JM, DIEZ N, DE SOUSA L, KIRIAKOS D, SÁNCHEZ E, FAKS J, ESCOLANO J, SANZ L. 2009. Snake venomics and antivenomics of Bothrops colombiensis, a medically importante pitviper of the Bothrops atrox-asper complex endemic to Venezuela: contributing to its taxonomy and snakebite management. J. Proteomics. 72(2):227-240.

CAMPBELL JA, LAMAR W. 1989. Venomous reptiles of Latin America. Comstock/Cornell University Press, Ithaca & London, UK, pp. 425.

CASTOE A, SASA M, PARKINSON C. 2005. Modeling nucleotide evolution at the mesoscale: the phylogeny of the Neotropical pitvipers of the Porthidium group (Viperidae: Crotalinae). Mol. Phylogenet. Evol. 37(3):881-898.

CASTRO H. 2006. Current status of snake venom thrombin like enzymes. Toxin Rev. 25(3):291-318.

CASTRO H, DUTRA D, OLIVEIRA A, ZINGALI R. 1998. Bothroalternin, a Thrombin inhibitor from the venom of Bothrops alternatus. Toxicon. 36(12):1903-1912.

CASTRO HC, ZINGALI RB, ALBUQUERQUE MG, PUJOL-LUZ M, RODRIGUES CR. 2004. Snake venom thrombin-like enzymes: from reptilase to now. Cell. Mol. Life Sci. 6(7-8):843-856.

CHIPPAUX J, WILLIAMS PV, WHITE J. 1991. Snake venom variability: methods of study, results and interpretation. Toxicon. 29(11):1279-1303.

CLEMETSON J. 2010. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon. 56(7):1236-1246.

CORNEJO-ESCOBAR P, DE SOUSA L, GREGORIANO T, BOADAS-MORALES J, GUZMÁN M, SÁNCHEZ D, VALERA-LEAL J. 2013. Primer reporte de envenenamiento humano causado por Porthidium lansbergii hutmanni (Serpentes, Viperidae) en la Isla de Coche, estado Nueva Esparta, noreste de Venezuela. Herpetotrópicos. 9(1-2):13-18.

CORTELAZZO A, GUERRANTI R, BINI L, HOPE-ONYEKWERE N, MUZZI C, LEONCINI R, PAGANI R. 2012 Effects of snake venom proteases on human fibrinogen chains. Blood Transfus. 8(Suppl 3):120-125.

DE SOUSA L, BASTOURI-CARRASCO J, MATOS M, BORGES A, BÓNOLI S, VÁSQUEZ-SUÁREZ A, GUERRERO B., RODRÍGUEZ-ACOSTA A. 2013. Epidemiología del ofidismo en Venezuela (1996-2004). Invest. Clin. 54(2):123-137.

DENNIS EA. 1973. Phospholipase A2 activity towards phosphatidylcholine in mixed micelles: surface dilution kinetics and the effect of thermotropic phase transitions. Arch. Biochem. Biophys. 158(2):485-493.

DU X, CLEMETSON K. 2002. Snake venom L-amino acid oxidases. Toxicon. 40(6):659-665.

ESCALANTE T, RUCAVADO A, FOX J, GUTIÉRREZ JM. 2011. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J. Proteomics. 74(9):1781-1794.

EVANS H, FRANSON R, QURESHI G, MOO-PENN W. 1980. Isolation of anticoagulant proteins from cobra venom (Naja nigricollis). Identity with phospholipases A2. J. Biol. Chem. 255(8):3793-3797.

FOX J, SERRANO S. 2005. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon. 45(8):969-985.

FOX J, SERRANO S. 2009. Timeline of key events in snake venom metalloproteinase research. J. Proteomics. 72(2):200-209.

FUENTES O, RODRÍGUEZ-ACOSTA A. 1997. Sobre los géneros Bothriechis, Bothriopsis y Porthidium (Serpentes: Crotalidae) existentes en Venezuela. Claves para su identificación de interés biomédico. Acta Biol. Venez. 17(3):31-38.

FRY B, VIDAL N, NORMAN J, VONK F, SCHEIB H, RAMJAN R, KURUPPU S, FUNG K, HEDGES B, RICHARDSON M, HODGSON W, IGNJATOVIC V, SUMMERHAYES R, KOCHVA E. 2006. Early evolution of the venom system in lizards and snakes. Nature. 439(7076):584-588.

FRY B, VIDAL N, VAN DER WEERD L, KOCHVA E, RENJIFO C. 2009. Evolution and diversification of the Toxicofera reptile venom system. J. Proteomics. 72(2):127-136.

GIBS HL, SANZ L, CHIUCCHI JE, FARRELL TM, CALVETE JJ. 2011. Proteomic analysis of ontogenetic and diet-related changes in venom composition of juvenile and adult Dusky Pigmy rattlesnakes (Sistrurus miliarius barbouri). J. Proteomics. 74(10):2169-2179.

GIRÓN ME, SALAZAR AM, AGUILAR I, PÉREZ J, SÁNCHEZ E, AROCHA-PIÑANGO C, RODRÍGUEZ-ACOSTA A, GUERRERO B. 2008. Hemorrhagic, coagulant and fibrino(geno)lytic activities of crude venom and fractions from mapanare (Bothrops colombiensis) snakes. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 147(1):113-121.

GIRÓN ME, RODRÍGUEZ-ACOSTA A, SALAZAR AM, SÁNCHEZ E, GALÁN J, IBARRA C, GUERRERO B. 2013. Isolation and characterization of two new nonhemorrhagic metalloproteinases with fibrinogenolytic activity from the mapanare (Bothrops colombiensis) venom. Arch. Toxicol. 87(1):197-208.

GIRÓN ME, PADRÓN V, RAMOS MI, SÁNCHEZ EE, GUERRERO B, GARCÍA A, UZCÁTEGUI NL, NAVARRETE LF, RODRÍGUEZ-ACOSTA A. 2018. Intraspecies geographical variability in the South American tigra mariposa (Bothrops venezuelensis Sandner 1952) snake venom activities. Toxicon. 144:23-33.

GUERCIO R, SHEVCHENKO A, LOPEZ J, PABA J, SOUSA M, RICART C. 2006. Ontogenic variations in the venom proteome of the Amazonian snake Bothrops atrox. Prot. Sci. 11:4-11.

GUO C, SHUQING L, YAO Y, ZHANG Q, SUN M. 2012. Past decade study of snake venom L-amino acid oxidase. Toxicon. 60(3):302-311.

GUTIÉRREZ JM. 2002. Comprendiendo los venenos de serpientes: 50 años de investigaciones en América Latina. Rev. Biol. Trop. 50(2):377-394.

GUTIÉRREZ JM, RUCAVADO A, ESCALANTE T, DÍAZ C. 2005. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms envolved in microvessel damage. Toxicon. 45(8):997-1011.

HSU C, WU W, HUANG T. 2008. A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions. J. Thromb. Haemost. 6(9):1578-1585.

INFANTE E. 2009. Primer registro de Porthidium lansbergii lansbergii Schlegel, 1841, en la Guajira venezolana, con comentarios sobre el género y la distribución en el estado Zulia. Herpetotrópicos. 5(1):25-28.

KAMIGUTI A. 2005. Platelets as targets of snake venom metalloproteinases. Toxicon. 45(8):1041-1049.

KAMIGUTI A, HAY C, THEAKSTON D, ZUZEL M. 1996a. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon. 34(6):627-642.

KAMIGUTI A, HAY C, ZUZEL M. 1996b. Inhibition of collagen-induced platelet aggregation as the result of cleavage of α2β1-integrin by the snake venom metalloproteinase jararhagin. Biochem. J. 320(2):635-641.

KASTURIRATNE A, WICKREMASINGHE R, DE SILVA N, GUNAWARDENA K, PATHMESWARAN A, PREMARATNA R, SAVIOLI L, LALLOO D, DE SILVA J. 2008. The global burden of snakebite: A literatura analysis and modelling base on regional estimates of envenoming and deaths. PLoS Med. 5(11):e218

KERNS R, KINI M, STEFANSSON S, EVANS H. 1999. Targeting of venom phospholipases: the strongly anticoagulant phospholipase A2 from Naja nigricollis binds to coagulation factor Xa to inhibit the prothrombinase complex. Arch. Biochem. Biophys. 369(2):107-113.

KINI M. 2005. The intriguing world of prothrombin activators from snake venom. Toxicon. 45(8):1133-1145.

KINI M. 2006. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem. J. 397(3):377-387.

KINI M. 2011. Toxins in thrombosis and haemostasis: potential beyond imagination. J. Thromb. Haemost. 9(Suppl. 1):195-208.

KINI M, EVANS H. 1990. Effects of snake venom proteins on blood platelets. Toxicon. 28(12):1387-1422.

KISIEL W, KONDO S, SMITH K, MCMULLEN B, SMITH L. 1987. Characterization of a Protein C activator from Agkistrodon contrortix contrortix venom. J. Biol. Chem. 262(26):12607-12613.

KOH DC, ARMUGAM A, JEYASEELAN K. 2006. Snake venom components and their applications in biomedicine. Cell Mol. Life Sci. 63(24):3030-3041.

LANCINI A. 1986. Serpientes de Venezuela. Segunda Edición. Ernesto Armitano Editor, Caracas, Venezuela, pp. 262.

LEE W, ZHANG Y, WANG W, XIONG Y, GAO R. 1995. Isolation and properties of a blood coagulation Factor X from the venom of King Cobra (Ophiophagus hannah). Toxicon. 33(10):1263-1276.

LEONARDI A, FOX J, TRAMPUS-BAKIJA A, KRIZAJ I. 2008. Two coagulation factor X activators from Vipera ammodytes venom with potential to treat patients with dysfunctional factors IXa or VIIa. Toxicon. 52(2):628-637.

LOMONTE B, REY-SUÁREZ P, TSAIA W, ANGULO Y, SASAA M, GUTIÉRREZ JM, CALVETE J. 2012. Snake venomics of the pit vipers Porthidium nasutum, Porthidium ophryomegas, and Cerrophidion godmani from Costa Rica: toxicological and taxonomical insights. J. Proteomics. 75(5):1675-1689.

LÓPEZ-JOHNSTON JC, DE BOSCH N, SCANNONE H, RODRÍGUEZ-ACOSTA A. 2007a. Inhibition of collagen, and thrombin-induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom. J. Thromb. Thrombol. 24(3):275-282.

LÓPEZ-JOHNSTON JC, DE BOSH N, SCANNONE H, RODRIGUEZ-ACOSTA A. 2007b. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom. Ann. Hematol. 86(12):879-885.

LU Q, CLEMETSON M, CLEMETSON KJ. 2005. Snake venoms and hemostasis. J. Thromb. Haemos. 3(8):1791-1799.

MARKLAND F. 1998. Snake venoms and hemostatic system. Toxicon. 36(12):1749-1800.

MARKLAND F, SWENSON S. 2010. Fibrolase: trials and tribulations. Toxins (Basel). 24):793-808.

MARKLAND F, SWENSON S. 2013. Snake venom metalloproteinases. Toxicon. 62:3-18.

MARSH N, WILLIAMS W. 2005. Practical applications of snake venom toxins in haemostasis. Toxicon. 45(8):1171-1181.

MENEZES M, FURTADO M, TRAVAGLIA-CARDOSO S, CAMARGO A, SERRANO S. 2006. Sex-based individual variation of snake venom proteome among eighteen Bothrops jararaca siblings. Toxicon. 47(3):304-312.

MORITA T. 2005. Structures and functions of snake venom CLPs (C-type lectin like proteins) with anticoagulant, procoagulant and platelet modulating activities. Toxicon. 45(8):1099-1114.

NAVARRETE L, LÓPEZ-JOHNSTON JC, BLANCO A. 2009. Guía de las Serpientes de Venezuela: Biología, venenos, conservación y listado de especies. Edición del Zoocriadero Ecopets, Caracas, Venezuela, pp.103.

NAVDAEV A, LOCHNIT G, EBLE J. 2011. Therhodocetinab subunit targets GPIb and inhibits von Willebrand factor induced platelet activation. Toxicon. 57(7-8):1041-1048.

OTERO R, GUTIÉRREZ J, BEATRIZ MESA M, DUQUE E, RODRÍGUEZ O, ARANGO J, GÓMEZ F, TORO A, CANO F, RODRÍGUEZ L, CARO E, MARTÍNEZ J, CORNEJO W, GÓMEZ L, URIBE F, CÁRDENAS S, NÚÑEZ V, DÍAZ A. 2002. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon. 40(8):1107-1114.

PÉREZ A, RUCAVADO A, SANZ L, CALVETE JJ, GUTIÉRREZ JM. 2008. Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper. Braz. J. Med. Biol. Res. 41(1):12-17.

PIFANO F, TRUJILLO M, RODRÍGUEZ-ACOSTA A. 1986. Sobre el emponzoñamiento producido por las corales ponzoñosas del trópico americano, especialmente en Venezuela. Med. Crit. Ven. 1(4):96-101.

PIRKLE H. 1998. Thrombin-like enzymes from snake venoms: an updated inventory. Thromb. Haemost. 79(3):675-683.

QUEIROZ G, PESSOA L, PORTARO F, FURTARO M, TAMBOURGI D. 2008. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus. Toxicon. 52(8):842-851.

RAMOS O, SELISTRE DE ARAUJO H. 2006. Snake venom metalloproteases structure and function of catalytic and disintegrin domains. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 1423-4):328-346.

RAO V, KINI M. 2002. Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex. Thromb. Haemost. 88(4):611-619.

RAO V, SWARUP S, KINI M. 2004. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structurally similar to mammalian blood coagulation factor Xa. Thromb. Haemost. 92(3):509-521.

RENGIFO C, RODRÍGUEZ-ACOSTA A. 2004. Serpientes, veneno y tratamiento médico en Venezuela. Fundación Fondo Editorial, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela, pp. 80.

RODRÍGUEZ-ACOSTA A, MONDOLFI A, ORIHUELA R, AGUILAR M. 1995 ¿Que hacer frente a un accidente ofídico? Venediciones, Caracas, Venezuela, pp. 46.

RODRÍGUEZ-ACOSTA A, UZCÁTEGUI W, AZUAJE R, AGUILAR I, GIRÓN ME. 2000. Análisis clínico y epidemiológico de los accidentes por mordeduras de serpientes del género Bothrops en Venezuela. Rev. Cubana. Med. Trop. 52(2):90-94.

ROSING J, TANS G. 1992. Structural and functional properties of snake venom prothrombin activators. Toxicon. 30(12):1515-1527.

ROSING J, GOVERS-RIEMSLAG J, YUKELSON L, TANS G. 2001. Factor V activation and inactivation by venom proteases. Haemostasis. 31(3-6):241-246.

SAJEVIC T, LEONARDI A, KRIZAJ I. 2011. Haemostatically active proteins in snake venoms. Toxicon. 57(5):627-645.

SAKURAI Y, SHIMA M, MATSUMOTO T, TAKATSUKA H, NISHIYA K, KASUDA S, FUJIMURA Y, YOSHIOKA A. 2003. Anticoagulant activity of M-LAO, L amino acid oxidase purified from Agkistrodon halys blomhoffi, through selective inhibition of factor IX. Biochem. Biophys. Acta. 1649(1):51-57.

SALAZAR AM, RODRÍGUEZ-ACOSTA A, GIRÓN ME, AGUILAR I, GUERRERO B. 2007. A comparative analysis of the clotting and fibrinolytic activities of the snake venom (Bothrops atrox) from different geographical areas in Venezuela. Thromb. Res. 120(1):95-104.

SELISTRE DE ARAUJO H, PONTES C, MONTENEGRO C, MARTIN C. 2010. Snake venom disintegrins and cell migration. Toxins (Basel). 2(11):2606-2621.

SERRANO S, MAROUN R. 2005. Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved. Toxicon. 45(8):1115-1132.

SIIGUR J, SIIGUR E. 2006. Factor X activating proteases from snake venoms. J. Toxicol Toxin Rev. 25(2):235-255.

SIIGUR E, MAHAR A, SIIGUR J. 1991. Beta-fibrinogenase from the venom of Vipera lebetina. Toxicon. 29(1):107-118.

SILVA-JUNIOR F, GUEDES H, GARVEYC L, AGUIARD A, BOURGUIGNON S, DI CERAC E, DE-SIMONEA S. 2007. BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: Role of N-glycosylation in thermostability and active site accessibility. Toxicon. 50(1):18-31.

SOUSA JR, MONTEIRO RQ, CASTRO HC, ZINGALI RB. 2001. Proteolytic action of Bothrops jararaca venom upon its own constituents. Toxicon. 39(6):787-792.

STOCKER K, FISHER H, MEIER J, BROGLI M, SVENDSEN L. 1987. Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortix) snake. Toxicon. 25(3):239-252.

SWENSON S, MARKLAND F. 2005. Snake venom fibrin(ogen)olytic enzymes. Toxicon. 45(8):1021-1039.

TAKEDA S, TAKEYA H, IWANAGA S. 2012. Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins. Biochim. Biophys. Acta. 1824(1):164-176.

TU A. 1977. Venoms: chemistry and molecular biology. Waley Intersciencie Publication, New York, USA, pp. 325.

VARGAS AM. 1997. Caracterización bioquímica y toxinológica del veneno de la serpiente venezolana Crotalus durissus cumanensis de diferentes regiones de Venezuela. Caracas: Universidad Central de Venezuela, Facultad de Farmacia [Trabajo de Ascenso Profesor Agregado], pp. 86.

VARGAS AM, FINOL H, GIRÓN ME, SCANNONE H, FERNÁNDEZ I, RODRÍGUEZ-ACOSTA A. 2011. Effects of Lansberg’s hognose pit vipers (Porthidium lansbergii hutmanni) venom on renal ultrastructure in experimental mice. Acta Scient. Vet. 39(1):941.

WALSH E, MARCINKIEWICZ C. 2011. Non-RGD-containing snake venom disintegrins, functional and structural relations. Toxicon. 58(4):355-362.

WHITE J. 2005. Snake venoms and coagulopathy. Toxicon. 45(8):951-967.

WU WB, PENG H, HUANG T. 2001. Crotalin, a vWF and GPIb cleaving metalloproteinase from venom Crotalus atrox. Thromb. Haemost. 86(6):1501-1511.

ZHANG Y, XIONG Y, BON C. 1995. An activator of blood coagulation factor X from the venom of Bungarus fasciatus. Toxicon. 33(10):1277-1288.

ZHOU Q, DANGELMAIER C, SMITH JB. 1996. The hemorrhagincatrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun. 219(3):720-726.

ZINGALI R, FERREIRA M, ASSAFI M, FRATTANI F, MONTEIRO M. 2005. Bothrojaracin, a Bothrops jararaca snake venom-derived (Pro)Thrombin Inhibitor, as an Anti-Thrombotic Molecule. Pathophysiol. Haemost. Thromb. 34(4-5):160-163.

Texto completo:

Referencias